Aclaris Therapeutics (ACRS) Reports Q4 Loss of $0.28/Share
Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 EPS of ($0.28), versus ($1.76) reported last year.
For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.
Aclaris Therapeutics (NASDAQ: ACRS) reported Q4 EPS of ($0.28), versus ($1.76) reported last year.
For earnings history and earnings-related data on Aclaris Therapeutics (ACRS) click here.